Covered recipient · General Payments record
TARA CARTER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023
$135.67
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $135.67 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $29.78 | 2 |
| Exact Sciences Corporation | $28.45 | 2 |
| Lilly USA, LLC | $19.72 | 1 |
| Novo Nordisk AS | $15.50 | 1 |
| PFIZER INC. | $14.57 | 1 |
| Acerta Pharma LLC | $13.85 | 1 |
| Merck Sharp & Dohme Corporation | $13.80 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $135.67 | 9 |
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $13.85 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015727261 | CMS |
| Exact Sciences Corporation | $13.48 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026856887 | CMS |
| Exact Sciences Corporation | $14.97 | 06/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026856945 | CMS |
| GlaxoSmithKline, LLC. | $14.05 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004043341 | CMS |
| GlaxoSmithKline, LLC. | $15.73 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004041955 | CMS |
| Lilly USA, LLC | $19.72 | 07/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033709269 | CMS |
| Merck Sharp & Dohme LLC | $13.80 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048730955 | CMS |
| Novo Nordisk Inc | $15.50 | 11/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002587513 | CMS |
| PFIZER INC. | $14.57 | 09/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049615941 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.